Fitbit (FIT) Trades Strong After Entering Potential 'Ground-Breaking' Breast Cancer Study
Tweet Send to a Friend
Fitbit (NYSE: FIT) is ramping to session highs Wednesday after it and Dana-Farber Cancer Institute announced a partnership to support ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


